PRESCRIPTION EVENT MONITORING - METHODOLOGY AND RECENT PROGRESS

被引:29
作者
RAWSON, NSB [1 ]
PEARCE, GL [1 ]
INMAN, WHW [1 ]
机构
[1] DRUG SAFETY RES UNIT,SOUTHAMPTON SO3 8BA,ENGLAND
关键词
Adverse drug reactions; Drug monitoring; Post-marketing surveillance; Prescription-event monitoring;
D O I
10.1016/0895-4356(90)90140-K
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Event monitoring was first suggested 25 years ago as a way of detecting adverse reactions to drugs. Prescription-event monitoring (PEM), which has been developed by the Drug Safety Research Unit, is the first large-scale systematic post-marketing surveillance method to use event monitoring in the U.K. PEM identifies patients, who have been prescribed a particular drug, and their doctors from photocopies of National Health Service prescriptions which are processed centrally in England. A personalized follow-up questionnaire ("green form") is mailed to each patient's general practitioner, usually on the first anniversary of the initial prescription, asking for information about the patient, especially any "events" that he or she may have experienced since beginning treatment with the drug. The methodology of PEM is presented, together with examples of analyses that can be performed using results from recent studies. The problems and benefits of PEM are discussed. © 1990.
引用
收藏
页码:509 / 522
页数:14
相关论文
共 34 条
[21]  
MANSFIELD BG, 1986, J ROY COLL GEN PRACT, V36, P405
[22]   PRINCIPLES OF NONEXPERIMENTAL ASSESSMENT OF EXCESS RISK, WITH SPECIAL REFERENCE TO ADVERSE DRUG-REACTIONS [J].
MIETTINEN, OS ;
CARO, JJ .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (04) :325-331
[23]  
MOULDS AJN, 1985, UPDATE, V30, P545
[24]  
NICHOLLS JT, 1978, MEDICO PHARMCAUTICAL, V7, P4
[25]  
O'Neill R T, 1987, Drug Inf J, V21, P9
[26]  
Rawson N S, 1986, Med Toxicol, V1 Suppl 1, P79
[27]  
RAWSON NSB, 1990, IN PRESS COMPREHENSI, V1
[28]  
RAWSON NSB, 1984, 2ND P WORLD C CLIN P, P939
[29]  
RAWSON NSB, 1987, THESIS U SOUTHAMPTON
[30]   POSTMARKETING SURVEILLANCE OF ENALAPRIL .2. INVESTIGATION OF THE POTENTIAL ROLE OF ENALAPRIL IN DEATHS WITH RENAL-FAILURE [J].
SPEIRS, CJ ;
DOLLERY, CT ;
INMAN, WHW ;
RAWSON, NSB ;
WILTON, LV .
BMJ-BRITISH MEDICAL JOURNAL, 1988, 297 (6652) :830-832